{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:45:48Z","timestamp":1777016748899,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013100","name":"Scientific Research Funds of Jilin Province of Health and Family Planning Commission","doi-asserted-by":"publisher","award":["2024A124"],"award-info":[{"award-number":["2024A124"]}],"id":[{"id":"10.13039\/501100013100","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013100","name":"Scientific Research Funds of Jilin Province of Health and Family Planning Commission","doi-asserted-by":"publisher","award":["2021JC096"],"award-info":[{"award-number":["2021JC096"]}],"id":[{"id":"10.13039\/501100013100","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015800","name":"Jilin Province Development and Reform Commission","doi-asserted-by":"publisher","award":["2021C042\\u20137"],"award-info":[{"award-number":["2021C042\\u20137"]}],"id":[{"id":"10.13039\/100015800","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013061","name":"Jilin Scientific and Technological Development Program","doi-asserted-by":"publisher","award":["20240304040SF"],"award-info":[{"award-number":["20240304040SF"]}],"id":[{"id":"10.13039\/501100013061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118712","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T12:08:42Z","timestamp":1761912522000},"page":"118712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A clinically translatable 2.5D lung adenocarcinoma organoid platform derived from malignant pleural effusions for precision drug screening and tumor-immune-stromal modeling"],"prefix":"10.1016","volume":"193","author":[{"given":"Shaowei","family":"Lan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1380-2207","authenticated-orcid":false,"given":"Chenchen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8634-9590","authenticated-orcid":false,"given":"Xinyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rixin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6422-0526","authenticated-orcid":false,"given":"Rui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8940-8445","authenticated-orcid":false,"given":"Ying","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2025.118712_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/cac2.12505","article-title":"Management of locally advanced non-small cell lung cancer: state of the art and future directions","volume":"44","author":"Miao","year":"2024","journal-title":"Cancer Commun."},{"issue":"11","key":"10.1016\/j.biopha.2025.118712_bib2","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S1470-2045(23)00444-8","article-title":"Global variations in lung cancer incidence by histological subtype in 2020: a population-based study","volume":"24","author":"Zhang","year":"2023","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118712_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cell.2020.05.043","article-title":"Integrative proteomic characterization of human lung adenocarcinoma","volume":"182","author":"Xu","year":"2020","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.biopha.2025.118712_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.NURSE.0000341079.53082.b1","article-title":"Caring for a patient with malignant pleural effusion","volume":"38","author":"Held-Warmkessel","year":"2008","journal-title":"Nursing"},{"issue":"1","key":"10.1016\/j.biopha.2025.118712_bib5","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1038\/s41598-024-53132-x","article-title":"Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid","volume":"14","author":"Bixby","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118712_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12931-024-02684-7","article-title":"Malignant pleural effusion: current understanding and therapeutic approach","volume":"25","author":"Gonnelli","year":"2024","journal-title":"Respir. Res."},{"issue":"6","key":"10.1016\/j.biopha.2025.118712_bib7","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/ijc.32262","article-title":"Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: functional analysis and expression of PD-1 receptor","volume":"145","author":"Tumino","year":"2019","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.biopha.2025.118712_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107542","article-title":"Establishing mesothelioma patient-derived organoid models from malignant pleural effusions","volume":"191","author":"Hocking","year":"2024","journal-title":"Lung Cancer"},{"issue":"8","key":"10.1016\/j.biopha.2025.118712_bib9","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1164\/rccm.201607-1404OC","article-title":"Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions. The ASAP trial","volume":"195","author":"Wahidi","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.biopha.2025.118712_bib10","article-title":"Interventions for the management of malignant pleural effusions: a network meta-analysis","author":"Dipper","year":"2020","journal-title":"Cochrane Database Syst. Rev. 4"},{"issue":"2","key":"10.1016\/j.biopha.2025.118712_bib11","article-title":"Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: a real-world study","volume":"4","author":"Wang","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"4","key":"10.1016\/j.biopha.2025.118712_bib12","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1021\/acsbiomaterials.8b01356","article-title":"Pleural effusion aspirate for use in 3D lung cancer modeling and chemotherapy screening","volume":"5","author":"Mazzocchi","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.biopha.2025.118712_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115224","article-title":"Enhanced detection of actionable mutations in NSCLC through pleural effusion cell-free DNA sequencing: a prospective study","volume":"217","author":"Wang","year":"2025","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2025.118712_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12935-025-03642-z","article-title":"Predictive value of dendritic cell-related genes for prognosis and immunotherapy response in lung adenocarcinoma","volume":"25","author":"Sun","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.biopha.2025.118712_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/cas.16450","article-title":"Multiple kinase small molecule inhibitor tinengotinib (TT-00420) alone or with chemotherapy inhibit the growth of SCLC","author":"Li","year":"2025","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2025.118712_bib16","doi-asserted-by":"crossref","first-page":"28951","DOI":"10.1038\/srep28951","article-title":"Capturing tumor complexity in vitro: comparative analysis of 2D and 3D tumor models for drug discovery","volume":"6","author":"Stock","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2025.118712_bib17","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/joa.12257","article-title":"Advances in 3D cell culture technologies enabling tissue-like structures to be created in vitro","volume":"227","author":"Knight","year":"2015","journal-title":"J. Anat."},{"issue":"17","key":"10.1016\/j.biopha.2025.118712_bib18","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.1158\/0008-5472.CAN-13-1069","article-title":"Patient-derived tumor xenografts: transforming clinical samples into mouse models","volume":"73","author":"Siolas","year":"2013","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.biopha.2025.118712_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111327","article-title":"Conditional reprogramming for patient-derived cancer models and next-generation living biobanks","volume":"8","author":"Palechor-Ceron","year":"2019","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.biopha.2025.118712_bib20","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.stem.2023.05.012","article-title":"Organoid cultures for cancer modeling","volume":"30","author":"Yan","year":"2023","journal-title":"Cell stem Cell"},{"issue":"4","key":"10.1016\/j.biopha.2025.118712_bib21","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1161\/CIRCRESAHA.122.321768","article-title":"Blood vessel organoids for development and disease","volume":"132","author":"Salewskij","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.118712_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-024-03489-3","article-title":"Clinical applications of human organoids","author":"Verstegen","year":"2025","journal-title":"Nat. Med"},{"issue":"3","key":"10.1016\/j.biopha.2025.118712_bib23","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.7150\/thno.91362","article-title":"Construction of tumor organoids and their application to cancer research and therapy","volume":"14","author":"Lv","year":"2024","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.biopha.2025.118712_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41563-021-01057-5","article-title":"Next-generation cancer organoids","volume":"21","author":"LeSavage","year":"2022","journal-title":"Nat. Mater."},{"issue":"1","key":"10.1016\/j.biopha.2025.118712_bib25","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12964-023-01332-9","article-title":"Applications of lung cancer organoids in precision medicine: from bench to bedside","volume":"21","author":"Li","year":"2023","journal-title":"Cell Commun. Signal. CCS"},{"issue":"1","key":"10.1016\/j.biopha.2025.118712_bib26","doi-asserted-by":"crossref","first-page":"9393","DOI":"10.1038\/s41598-020-66229-w","article-title":"Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture","volume":"10","author":"Abugomaa","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118712_bib27","article-title":"Establishment of a direct 2.5D organoid culture model using companion animal cancer tissues","volume":"154","author":"Abugomaa","year":"2022","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.biopha.2025.118712_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104580","article-title":"A systematic characterization of microglia-like cell occurrence during retinal organoid differentiation","volume":"25","author":"Bartalska","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.biopha.2025.118712_bib29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.addr.2017.12.013","article-title":"Engineered cell and tissue models of pulmonary fibrosis","volume":"129","author":"Sundarakrishnan","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"23","key":"10.1016\/j.biopha.2025.118712_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25235751","article-title":"The optimization of a novel hydrogel-egg white-alginate for 2.5D tissue engineering of salivary spheroid-like structure","volume":"25","author":"Zhang","year":"2020","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.biopha.2025.118712_bib31","first-page":"409","article-title":"Incorporation of stem cell-derived astrocytes into neuronal organoids to allow neuro-glial interactions in toxicological studies","volume":"37","author":"Br\u00fcll","year":"2020","journal-title":"Altex"},{"issue":"1","key":"10.1016\/j.biopha.2025.118712_bib32","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3892\/ol.2024.14431","article-title":"Mechanism of targeting the mTOR pathway to regulate ferroptosis in NSCLC with different EGFR mutations","volume":"28","author":"Wu","year":"2024","journal-title":"Oncol. Lett."},{"issue":"16","key":"10.1016\/j.biopha.2025.118712_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169158","article-title":"Looking into the eyes-in vitro models for ocular research","volume":"23","author":"Lieto","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2025.118712_bib34","first-page":"647","article-title":"Three-dimensional organotypic culture: experimental models of mammalian biology and disease, nature reviews","volume":"15","author":"Shamir","year":"2014","journal-title":"Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118712_bib35","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.stem.2024.03.008","article-title":"Patient-derived tumor-like cell clusters for personalized chemo- and immunotherapies in non-small cell lung cancer","volume":"31","author":"Yin","year":"2024","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.biopha.2025.118712_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006290","article-title":"Emerging organoid-immune co-culture models for cancer research: from oncoimmunology to personalized immunotherapies","volume":"11","author":"Magr\u00e9","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2025.118712_bib37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13045-022-01278-4","article-title":"Tumor organoids: applications in cancer modeling and potentials in precision medicine","volume":"15","author":"Xu","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118712_bib38","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.it.2020.06.010","article-title":"Organoid models of tumor immunology","volume":"41","author":"Yuki","year":"2020","journal-title":"Trends Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118712_bib39","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","article-title":"Organoid modeling of the tumor immune microenvironment","volume":"175","author":"Neal","year":"2018","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biopha.2025.118712_bib40","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/acd1b8","article-title":"Reconstruction of tumor microenvironment viain vitrothree-dimensional models","volume":"15","author":"Zhou","year":"2023","journal-title":"Biofabrication"},{"key":"10.1016\/j.biopha.2025.118712_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216586","article-title":"Single-cell transcriptome profiling of primary tumors and paired organoids of pancreatobiliary cancer","volume":"582","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.biopha.2025.118712_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1656","article-title":"Tumour organoids and assembloids: patient-derived cancer avatars for immunotherapy","volume":"14","author":"Mei","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.biopha.2025.118712_bib43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/CH-219111","article-title":"Generation of 2.5D lung bud organoids from human induced pluripotent stem cells","volume":"79","author":"Xu","year":"2021","journal-title":"Clin. Hemorheol. Microcirc."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:15:52Z","timestamp":1777014952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225009060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":43,"alternative-id":["S0753332225009060"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118712","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A clinically translatable 2.5D lung adenocarcinoma organoid platform derived from malignant pleural effusions for precision drug screening and tumor-immune-stromal modeling","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118712","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118712"}}